Harrod Virginia L, Howard Thad A, Zimmerman Sherri A, Dertinger Stephen D, Ware Russell E
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Exp Hematol. 2007 Feb;35(2):179-83. doi: 10.1016/j.exphem.2006.09.013.
Although functional asplenia in sickle cell disease (SCD) begins early in life and has important clinical consequences, quantitative measurement of splenic function is not readily available. A novel high-throughput flow cytometric method for quantitating Howell-Jolly bodies (HJB) has been developed which isolates HJB-containing CD71(+) and CD71(-) erythrocytes. Analysis of these cell populations allows quantitative measurement of splenic filtrative function and possible chromosomal damage.
Blood specimens from 147 children with SCD were analyzed using a high-throughput flow cytometric method. Enumeration of the following populations was accomplished: 1) CD71(+) reticulocytes among total erythrocytes, identifying the youngest erythroid cell population; 2) HJB-containing CD71(+) reticulocytes, which isolate young erythrocytes containing micronuclei as an index of cytogenetic damage; and 3) HJB-containing CD71(-) erythrocytes, identifying older erythrocytes containing micronuclei, indirectly measuring splenic function.
Children with HbSC (n = 24) had slightly elevated HJB frequencies, while children with HbSS (n = 125) had highly elevated frequencies within CD71(+) cells (0.44% +/- 0.40%, normal 0.12% +/- 0.06%, p < 0.001) and CD71(-) cells (2493 +/- 2303 per million RBC, normal 20 +/- 11, p < 0.001). Using a multiple regression model, the frequency of HbSS CD71(+) reticulocytes containing HJB was significantly influenced by hydroxyurea use (p < 0.0001), age (p = 0.0288), and splenectomy (p = 0.0498). Similarly, mature CD71(-) erythrocytes containing HJB were positively correlated with hydroxyurea (p = 0.0001), age (p < 0.0001), and splenectomy (p = 0.0104).
HJB quantitation by flow cytometry is a novel assay for measuring splenic function and may be valuable for investigating the efficacy and safety of therapeutic options for children with SCD.
尽管镰状细胞病(SCD)患者的功能性无脾在生命早期就已出现并具有重要的临床后果,但脾功能的定量测量方法尚不完善。一种用于定量豪-焦小体(HJB)的新型高通量流式细胞术方法已被开发出来,该方法可分离出含有HJB的CD71(+)和CD71(-)红细胞。对这些细胞群体的分析有助于定量测量脾脏的过滤功能以及可能存在的染色体损伤。
采用高通量流式细胞术方法对147例SCD患儿的血液标本进行分析。完成以下细胞群体的计数:1)总红细胞中的CD71(+)网织红细胞,可识别最年轻的红细胞群体;2)含有HJB的CD71(+)网织红细胞,可分离出含有微核的年轻红细胞,作为细胞遗传损伤的指标;3)含有HJB的CD71(-)红细胞,可识别含有微核的较老红细胞,间接测量脾脏功能。
HbSC患儿(n = 24)的HJB频率略有升高,而HbSS患儿(n = 125)的CD71(+)细胞(0.44% ± 0.40%,正常为0.12% ± 0.06%,p < 0.001)和CD71(-)细胞(每百万红细胞中2493 ± 2303个,正常为20 ± 11个,p < 0.001)中的HJB频率则显著升高。使用多元回归模型,含有HJB的HbSS CD71(+)网织红细胞的频率受羟基脲使用情况(p < 0.0001)、年龄(p = 0.0288)和脾切除术(p = 0.0498)的显著影响。同样,含有HJB的成熟CD71(-)红细胞与羟基脲(p = 0.0001)、年龄(p < 但未给出具体值)和脾切除术(p = 0.0104)呈正相关。
通过流式细胞术对HJB进行定量分析是一种测量脾脏功能的新方法,对于研究SCD患儿治疗方案的疗效和安全性可能具有重要价值。